Showing results (11-20 of 98) with videos related to
Sort By:
Pageof 10
Pathologie-Biologie|March 1, 1987
[Immunogenetics of multiple sclerosis]M Clanet, A Cambon-Thomsen, A RascolFundamental & Clinical Pharmacology|January 1, 1989
Calcium antagonists and the vestibular system: a critical review of flunarizine as an antivertigo drugO Rascol, M Clanet, J L MontastrucJournal of the Neurological Sciences|February 1, 2003
Clinical-MRI correlations in the secondary progressive phase of MS: lessons from the treatment trialsM Clanet, E Cassol, C Manelfe, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
Interferons and multiple sclerosisM Clanet, A Blancher, P Calvas, et al.Revue Neurologique|January 1, 1992
[Recurrent Neisseria meningitidis meningitis associated with homozygote complement C7 fraction deficiency]G Angibaud, G Durand, A Rascol, et al.La Revue Du Praticien|September 15, 1991
[New imaging methods by nuclear magnetic resonance in multiple sclerosis]C Mekies, I Berry, C Manelfe, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|May 6, 2004
Interferon beta-1a in relapsing multiple sclerosis: four-year extension of the European IFNbeta-1a Dose-Comparison StudyM Clanet, L Kappos, H P Hartung, et al.Revue Neurologique|November 1, 1995
[Potential value of hyperbaric oxygenation in the treatment of post-radiation myelopathies]G Angibaud, J L Ducassé, G Baillé, et al.Revue Neurologique|November 11, 1998
[MRI visualization of multiple sclerosis lesions]I Berry, J P Ranjeva, C Manelfe, et al.European Neurology|January 1, 1995
Treatment of hemifacial spasm with botulinum toxin. Value of preinjection electromyography abnormalities for predicting postinjection lower facial paresisG Angibaud, M S Moreau, O Rascol, et al.Pageof 10